Sign in to continue:

Friday, March 20th, 2026

Bunge Global SA Prices $1.2 Billion Senior Notes Offering for General Corporate Purposes





Bunge Global SA Announces \$1.2 Billion Senior Notes Offering

Bunge Global SA Announces Pricing of \$1.2 Billion Senior Notes Offering

Key Highlights for Investors

  • Issuer: Bunge Global SA (NYSE: BG) via its wholly owned subsidiary Bunge Limited Finance Corp.
  • Offering: Successfully priced a \$1.2 billion public offering of senior unsecured notes.
  • Structure: The offering consists of two tranches:
    • \$500 million of 4.800% Senior Notes due 2033 (“2033 Notes”)
    • \$700 million of 5.150% Senior Notes due 2036 (“2036 Notes”)
  • Guarantee: The Senior Notes are fully and unconditionally guaranteed by Bunge Global SA on a senior unsecured basis.
  • Use of Proceeds: Net proceeds will be used for general corporate purposes, which may include debt repayment/refinancing (including short-term debt), working capital, capital expenditures, stock repurchases, and investments in subsidiaries.
  • Expected Closing: March 19, 2026, subject to customary closing conditions.
  • Offering Managers: Leading global financial institutions are acting as joint book-running managers and co-managers, highlighting strong market confidence and support.

Potential Shareholder Impact and Price-Sensitive Information

This offering is significant for shareholders for several reasons:

  • Capital Structure Flexibility: The \$1.2 billion capital raise enhances Bunge’s financial flexibility, supporting potential deleveraging, growth investments, or shareholder returns (e.g., stock repurchases). This can positively impact share value, especially if used to reduce expensive short-term debt or fund value-accretive projects.
  • Interest Rates: The fixed rates (4.800% and 5.150%) lock in current borrowing costs, providing predictability at a time when interest rate volatility is a concern for many corporates.
  • Strategic Use of Proceeds: The broad application of proceeds (including possible acquisitions, investments, and buybacks) gives management flexibility to respond to market opportunities and return capital to shareholders.
  • Market Confidence: The participation of top-tier global banks as joint bookrunners suggests strong institutional demand for Bunge’s debt, which reflects market confidence in the company’s creditworthiness and outlook.

Company Overview

Bunge Global SA is a premier global agribusiness and food company, employing approximately 34,000 people and operating in over 50 countries. The company is a world leader in grain origination, storage, distribution, oilseed processing, and refining. Bunge also provides a broad portfolio of plant-based oils, fats, and proteins and is focused on connecting farmers to consumers efficiently and sustainably.

Bunge’s business model is highly sensitive to global commodity prices, supply chain factors, weather conditions, and geopolitical risks (notably the impact of the war in Ukraine and related sanctions on Russia). The company is also advancing its sustainability initiatives and continuing its business combination with Viterra Limited, which may have further strategic implications for shareholders.

Risks and Forward-Looking Statements

Management explicitly cautions investors on forward-looking statements related to the offering. Key risks include:

  • Ability to complete the offering as planned
  • Impact from the war in Ukraine and sanctions on Russia
  • Weather conditions and crop/animal disease
  • Commodity market and macroeconomic volatility
  • Changes in government policies, regulation, and tax
  • Integration risks related to acquisitions, including Viterra
  • Operational risks (accidents, cyber, pandemics, etc.)
  • Foreign exchange risks and third-party dependencies

Investors should review Bunge’s most recent filings, including the Annual Report on Form 10-K for the year ended December 31, 2025, for a complete discussion of risk factors.

How to Access the Prospectus

The offering is being made only by means of the prospectus supplement and accompanying prospectus, which can be obtained from the lead managers (SMBC Nikko Securities America, Citigroup Global Markets, or J.P. Morgan Securities).



Disclaimer: This article contains information based on Bunge Global SA’s public SEC filings and press releases. It includes forward-looking statements that are subject to risks and uncertainties. This article does not constitute an offer to sell or a solicitation of an offer to buy any securities. Investors should consult the official filings and seek professional advice before making investment decisions.




View Bunge Global SA Historical chart here



Galectin Therapeutics Appoints Dr. Henry Brem to Board, Advancing Belapectin for MASH Cirrhosis and Cancer Therapies

Galectin Therapeutics Appoints Dr. Henry Brem to Board, Bols...

Lionsgate Studios Corp. Files Form 8-K With SEC: Key Company Information and Filing Details (March 17, 2026)

Lionsgate Studios Corp. 2026 Annual General & Special Meetin...

Crown Castle Inc. 2025 Annual Report: Business Overview, Risk Factors, Strategy, and Financial Highlights

Crown Castle Inc. 2025 Annual Report: Key Investor Highlight...

   Ad